Thyroid function after diagnostic 123I-metaiodobenzylguanidine in children with neuroblastic tumors
ConclusionsThe prevalence of thyroid dysfunction does not seem to be increased in patients with neuroblastic tumors who received123I-MIBG combined with thyroid protection. Randomized controlled trials are required to investigate whether administration of123I-MIBG without thyroid protection is harmful to the thyroid gland.
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
More News: Brain | Children | Neuroblastoma | Neurology | Nuclear Medicine | Potassium | Study | Thyroid